{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T11:51:26Z","timestamp":1671277886045},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,6,19]],"date-time":"2015-06-19T00:00:00Z","timestamp":1434672000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12879-015-0953-5","type":"journal-article","created":{"date-parts":[[2015,6,17]],"date-time":"2015-06-17T23:02:04Z","timestamp":1434582124000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Sample size considerations using mathematical models: an example with Chlamydia trachomatis infection and its sequelae pelvic inflammatory disease"],"prefix":"10.1186","volume":"15","author":[{"given":"Sereina A","family":"Herzog","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola","family":"Low","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Berghold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,6,19]]},"reference":[{"key":"953_CR1","doi-asserted-by":"publisher","first-page":"e1001250","DOI":"10.1371\/journal.pmed.1001250","volume":"9","author":"M Boily","year":"2012","unstructured":"Boily M, M\u00e2sse B, Alsallaq R, Padian NS, Eaton JW, Vesga JF, et al. HIV treatment as prevention: considerations in the design, conduct, and analysis of cluster randomized controlled trials of combination HIV prevention. PLoS Med. 2012;9:e1001250.","journal-title":"PLoS Med"},{"key":"953_CR2","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s10654-009-9397-9","volume":"25","author":"MC Chubb","year":"2010","unstructured":"Chubb MC, Jacobsen KH. Mathematical modeling and the epidemiological research process. Eur J Epidemiol. 2010;25:13\u20139.","journal-title":"Eur J Epidemiol"},{"key":"953_CR3","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/S0140-6736(10)61505-X","volume":"378","author":"GP Garnett","year":"2011","unstructured":"Garnett GP, Cousens S, Hallett TB, Steketee R, Walker N. Mathematical models in the evaluation of health programmes. Lancet. 2011;378:515\u201325.","journal-title":"Lancet"},{"key":"953_CR4","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1097\/00001648-199109000-00004","volume":"2","author":"ME Halloran","year":"1991","unstructured":"Halloran ME, Struchiner CJ. Study designs for dependent happenings. Epidemiology. 1991;2:331\u20138.","journal-title":"Epidemiology"},{"key":"953_CR5","doi-asserted-by":"publisher","first-page":"e84511","DOI":"10.1371\/journal.pone.0084511","volume":"9","author":"A Cori","year":"2014","unstructured":"Cori A, Ayles H, Beyers N, Schaap A, Floyd S, Sabapathy K, et al. HPTN 071 (PopART): a cluster-randomized trial of the population impact of an HIV combination prevention intervention including universal testing and treatment: mathematical model. PLoS One. 2014;9:e84511.","journal-title":"PLoS One"},{"key":"953_CR6","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/1745-6215-15-57","volume":"15","author":"R Hayes","year":"2014","unstructured":"Hayes R, Ayles H, Beyers N, Sabapathy K, Floyd S, Shanaube K, et al. HPTN 071 (PopART): rationale and design of a cluster-randomised trial of the population impact of an HIV combination prevention intervention including universal testing and treatment - a study protocol for a cluster randomised trial. Trials. 2014;15:57.","journal-title":"Trials"},{"key":"953_CR7","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1097\/OLQ.0b013e31825159ff","volume":"39","author":"SA Herzog","year":"2012","unstructured":"Herzog SA, Heijne JCM, Althaus CL, Low N. Describing the progression from Chlamydia trachomatis and Neisseria gonorrhoeae to pelvic inflammatory disease: systematic review of mathematical modeling studies. Sex Transm Dis. 2012;39:628\u201337.","journal-title":"Sex Transm Dis"},{"key":"953_CR8","first-page":"1017","volume-title":"Sexually Transmitted Diseases","author":"J Paavonen","year":"2008","unstructured":"Paavonen J, Westr\u00f6m L, Eschenbach D. Pelvic Inflammatory Disease. In: Holmes KK, Sparling PF, Stamm W, Piot P, Wasserheit J, Corey L, Cohen M, editors. Sexually Transmitted Diseases. 4th ed. New York: McGraw-Hill Medical; 2008. p. 1017\u201350.","edition":"4"},{"key":"953_CR9","volume-title":"Global Incidence and Prevalence of Selected Curable Sexually Transmitted Infections - 2008","author":"World Health Organization","year":"2012","unstructured":"World Health Organization. Global Incidence and Prevalence of Selected Curable Sexually Transmitted Infections - 2008. Geneva, Switzerland: World Health Organization; 2012."},{"key":"953_CR10","first-page":"575","volume-title":"Sexually Transmitted Diseases","author":"WE Stamm","year":"2008","unstructured":"Stamm WE. Chlamydia Trachomatis Infections of the Adult. In: Holmes KK, Sparling PF, Stamm W, Piot P, Wasserheit J, Corey L, Cohen M, editors. Sexually Transmitted Diseases. 4th ed. New York: McGraw-Hill Medical; 2008. p. 575\u201393.","edition":"4"},{"key":"953_CR11","doi-asserted-by":"publisher","first-page":"S190","DOI":"10.1086\/652401","volume":"201","author":"SL Gottlieb","year":"2010","unstructured":"Gottlieb SL, Martin DH, Xu F, Byrne GI, Brunham RC. Summary: the natural history and immunobiology of Chlamydia trachomatis genital infection and implications for chlamydia control. J Infect Dis. 2010;201:S190\u2013204.","journal-title":"J Infect Dis"},{"key":"953_CR12","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/OLQ.0b013e31827bd637","volume":"40","author":"SL Gottlieb","year":"2013","unstructured":"Gottlieb SL, Xu F, Brunham RC. Screening and treating Chlamydia trachomatis genital infection to prevent pelvic inflammatory disease: interpretation of findings from randomized controlled trials. Sex Transm Dis. 2013;40:97\u2013102.","journal-title":"Sex Transm Dis"},{"key":"953_CR13","doi-asserted-by":"publisher","first-page":"S134","DOI":"10.1086\/652395","volume":"201","author":"CL Haggerty","year":"2010","unstructured":"Haggerty CL, Gottlieb SL, Taylor BD, Low N, Xu F, Ness RB. Risk of sequelae after Chlamydia trachomatis genital infection in women. J Infect Dis. 2010;201:S134\u201355.","journal-title":"J Infect Dis"},{"key":"953_CR14","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/1745-6215-9-73","volume":"9","author":"P Oakeshott","year":"2008","unstructured":"Oakeshott P, Kerry S, Atherton H, Aghaizu A, Hay S, Taylor-Robinson D, et al. Community-based trial of screening for Chlamydia trachomatis to prevent pelvic inflammatory disease: the POPI (prevention of pelvic infection) trial. Trials. 2008;9:73.","journal-title":"Trials"},{"key":"953_CR15","doi-asserted-by":"publisher","first-page":"c1642","DOI":"10.1136\/bmj.c1642","volume":"340","author":"P Oakeshott","year":"2010","unstructured":"Oakeshott P, Kerry S, Aghaizu A, Atherton H, Hay S, Taylor-Robinson D, et al. Randomised controlled trial of screening for Chlamydia trachomatis to prevent pelvic inflammatory disease: the POPI (prevention of pelvic infection) trial. BMJ. 2010;340:c1642.","journal-title":"BMJ"},{"key":"953_CR16","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1186\/1471-2334-12-187","volume":"12","author":"SA Herzog","year":"2012","unstructured":"Herzog SA, Althaus CL, Heijne JCM, Oakeshott P, Kerry S, Hay P, et al. Timing of progression from Chlamydia trachomatis infection to pelvic inflammatory disease: a mathematical model. BMC Infect Dis. 2012;12:187.","journal-title":"BMC Infect Dis"},{"key":"953_CR17","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.epidem.2010.04.002","volume":"2","author":"CL Althaus","year":"2010","unstructured":"Althaus CL, Heijne JCM, Roellin A, Low N. Transmission dynamics of Chlamydia trachomatis affect the impact of screening programmes. Epidemics. 2010;2:123\u201331.","journal-title":"Epidemics"},{"key":"953_CR18","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1086\/428287","volume":"191","author":"M Molano","year":"2005","unstructured":"Molano M, Meijer CJLM, Weiderpass E, Arslan A, Posso H, Franceschi S, et al. The natural course of Chlamydia trachomatis infection in asymptomatic Colombian women: a 5-year follow-up study. J Infect Dis. 2005;191:907\u201316.","journal-title":"J Infect Dis"},{"key":"953_CR19","volume-title":"Essential Medical Statistics","author":"BR Kirkwood","year":"2003","unstructured":"Kirkwood BR, Sterne JAC. Essential Medical Statistics. 2nd ed. Malden, Mass: Blackwell Science; 2003.","edition":"2"},{"key":"953_CR20","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1056\/NEJM199605233342103","volume":"334","author":"D Scholes","year":"1996","unstructured":"Scholes D, Stergachis A, Heidrich FE, Andrilla H, Holmes KK, Stamm WE. Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection. N Engl J Med. 1996;334:1362\u20136.","journal-title":"N Engl J Med"},{"key":"953_CR21","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1097\/01.AOG.0000139512.37582.17","volume":"104","author":"RB Ness","year":"2004","unstructured":"Ness RB, Hillier SL, Kip KE, Soper DE, Stamm CA, McGregor JA, et al. Bacterial vaginosis and risk of pelvic inflammatory disease. Obstet Gynecol. 2004;104:761\u20139.","journal-title":"Obstet Gynecol"},{"key":"953_CR22","volume-title":"Mathematica","author":"I Wolfram Research","year":"2014","unstructured":"Wolfram Research I. Mathematica. Champaign, Illinois: Wolfram Research, Inc.; 2014."},{"key":"953_CR23","volume-title":"R: A Language and Environment for Statistical Computing. 64Bit","author":"R Core Team","year":"2014","unstructured":"R Core Team. R: A Language and Environment for Statistical Computing. 64Bit. Vienna, Austria: R Foundation for Statistical Computing; 2014."},{"key":"953_CR24","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1111\/j.1524-4733.2007.00189.x","volume":"10","author":"KJ Smith","year":"2007","unstructured":"Smith KJ, Cook RL, Roberts MS. Time from sexually transmitted infection acquisition to pelvic inflammatory disease development: influence on the cost-effectiveness of different screening intervals. Value Health. 2007;10:358\u201366.","journal-title":"Value Health"},{"key":"953_CR25","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1097\/OLQ.0b013e31824717ae","volume":"39","author":"AR Tuite","year":"2012","unstructured":"Tuite AR, Jayaraman GC, Allen VG, Fisman DN. Estimation of the burden of disease and costs of genital Chlamydia trachomatis infection in Canada. Sex Transm Dis. 2012;39:260\u20137.","journal-title":"Sex Transm Dis"},{"key":"953_CR26","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1086\/598983","volume":"199","author":"RT Gray","year":"2009","unstructured":"Gray RT, Beagley KW, Timms P, Wilson DP. Modeling the impact of potential vaccines on epidemics of sexually transmitted Chlamydia trachomatis infection. J Infect Dis. 2009;199:1680\u20138.","journal-title":"J Infect Dis"},{"key":"953_CR27","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1136\/bmj.317.7150.26","volume":"317","author":"L \u00d8stergaard","year":"1998","unstructured":"\u00d8stergaard L, Andersen B, Olesen F, M\u00f8ller JK. Efficacy of home sampling for screening of Chlamydia trachomatis: randomised study. BMJ. 1998;317:26\u20137.","journal-title":"BMJ"},{"key":"953_CR28","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1093\/aje\/kws583","volume":"178","author":"MJ Price","year":"2013","unstructured":"Price MJ, Ades AE, Angelis D d, Welton NJ, Macleod J, Soldan K, et al. Risk of pelvic inflammatory disease following Chlamydia trachomatis infection: analysis of prospective studies with a multistate model. Am J Epidemiol. 2013;178:484\u201392.","journal-title":"Am J Epidemiol"},{"key":"953_CR29","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1097\/OLQ.0b013e3181b9d825","volume":"36","author":"LE Manhart","year":"2009","unstructured":"Manhart LE. Has the time come to systematically test for Mycoplasma genitalium? Sex Transm Dis. 2009;36:607\u20138.","journal-title":"Sex Transm Dis"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-015-0953-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-015-0953-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-015-0953-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-015-0953-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,27]],"date-time":"2019-08-27T05:21:31Z","timestamp":1566883291000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-015-0953-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,19]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["953"],"URL":"https:\/\/doi.org\/10.1186\/s12879-015-0953-5","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,19]]},"article-number":"233"}}